Torrent Pharma's India sales grew 11% year-on-year, led by out performance in the focused therapies as its chronic sales grew ...

BEL share price slips despite strong margins and order inflows; Nomura downgrades, while UBS and JP Morgan stay bullish.

Of the 44 analysts that have coverage on IndusInd Bank, 24 of them continue to have a 'Sell' rating, 14 say 'Hold', while six ...

Laurus Labs' share price surged 8% to an all-time high of ₹901, driven by strong Q1 FY26 earnings. Analysts raised target ...

Global brokerage Citi has maintained a 'Sell' rating with a target of ₹765 per share, according to reports. The brokerage ...

Antique wrote in its note that a major trigger for Mazagon Dock will be the order for three additional Scorpene submarines, ...

SBI Cards shares fell 6.1% to ₹834.75 after weak June quarter results, marking a fourth straight profit decline. Net profit ...

Elevated slippages led to higher credit costs, and brokerages expects return on assets (RoAs) to stay below 1 percent in the near term.

Zen Technologies' Q1 results were muted given a slowdown in order inflow momentum that persisted for a fifth quarter in a row ...

Out of the 29 analysts tracking BEL, 23 have a 'buy' rating on the stock, two recommend a 'hold' and four suggest a 'sell', ...

IndusInd Bank posts steep profit drop in Q1FY26 as asset quality deteriorates; see what brokerages recommend for investors.

Analysts have revised their ratings and price targets for SBI Cards and Payment Services stock, sending a mixed-to-cautious ...